Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis

BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with limited treatment options and poor prognosis. Capecitabine, as a novel adjuvant chemotherapy for TNBCs, remains controversial. Therefore, we conducted this meta-analysis to assess the efficacy and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xun, Xueqiong, Cao, Qinguang, Hong, Pan, Rai, Saroj, Zhou, Yeming, Liu, Ruikang, Hu, Huiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300946/
https://www.ncbi.nlm.nih.gov/pubmed/35875141
http://dx.doi.org/10.3389/fonc.2022.899423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300946/
https://www.ncbi.nlm.nih.gov/pubmed/35875141
http://dx.doi.org/10.3389/fonc.2022.899423

Ejemplares similares